Related Experiment Videos
[Ascorbigen and its derivatives--depot preparations of ascorbic acid]
Bioorganicheskaia Khimiia
|April 1, 1987
Summary
New ascorbigen derivatives were synthesized and found to rapidly release L-ascorbic acid in solution. In vivo studies showed that 1-methylascorbigen administration increased L-ascorbic acid levels in mouse blood plasma.
Area of Science:
- Biochemistry
- Organic Chemistry
- Pharmacology
Background:
- Ascorbigen derivatives are novel compounds with potential biological activity.
- Understanding their stability and release kinetics is crucial for potential therapeutic applications.
Purpose of the Study:
- To synthesize new ascorbigen derivatives.
- To investigate the stability and L-ascorbic acid release of these derivatives in aqueous solutions.
- To evaluate the in vivo effect of a specific derivative on L-ascorbic acid levels.
Main Methods:
- Chemical synthesis of ascorbigen derivatives (1'-ethylascorbigen, 1'-benzylascorbigen, 1',2'-dimethyl-5'-methoxyascorbigen).
- Assay of L-ascorbic acid release in aqueous solutions at physiological conditions (temperature and pH).
- Intraperitoneal injection of 1'-methylascorbigen to mice and subsequent blood plasma analysis.
Main Results:
- Successful synthesis of three new ascorbigen derivatives.
- Ascorbigen derivatives demonstrated rapid disintegration in aqueous solutions, yielding L-ascorbic acid.
- The rate of L-ascorbic acid formation was influenced by the indole nucleus substituent, pH, and temperature.
- Intraperitoneal administration of 1'-methylascorbigen resulted in elevated L-ascorbic acid levels in mouse blood plasma.
Conclusions:
- The synthesized ascorbigen derivatives are labile in aqueous solutions, serving as potential precursors for L-ascorbic acid.
- The release of L-ascorbic acid is controllable by chemical structure and environmental factors.
- 1'-methylascorbigen shows potential for increasing L-ascorbic acid levels in vivo.